Megan Schultz, MD
Internal Medicine · Lexington, KYNPI 1831551076
Payments from drug & device makers
Across 214 payments — averaging $15.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$536
- Pfizer$405
- Lilly USA, LLC$316
- Novo Nordisk$274
- GSK$252
- Boehringer Ingelheim$232
- plus $1K from 29 others
What the payments were for
- Food & beverage$3,340100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 36 | $536 |
| Pfizer | 27 | $405 |
| Lilly USA, LLC | 18 | $316 |
| Novo Nordisk | 18 | $274 |
| GSK | 16 | $252 |
| Boehringer Ingelheim | 16 | $232 |
| Amgen | 14 | $224 |
| Novartis | 7 | $128 |
| Bayer | 6 | $92 |
| Upsher-smith Laboratories LLC | 5 | $84 |
| Sumitomo Pharma America, Inc. | 4 | $77 |
| Sanofi-aventis U.S. LLC | 6 | $73 |
| Merck | 5 | $70 |
| Teva Pharmaceuticals USA, Inc. | 4 | $58 |
| Dynavax Technologies Corporation | 3 | $58 |
| Abbott | 3 | $54 |
| Esperion Therapeutics, Inc. | 4 | $53 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $40 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| Biohaven Pharmaceuticals, Inc. | 2 | $26 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| CSL Behring | 1 | $20 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
| Johnson & Johnson | 1 | $18 |
| Sage Therapeutics, LLC | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| AstraZeneca | 1 | $15 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Exact Sciences | 1 | $14 |
| Corcept Therapeutics | 1 | $14 |
| Biogen | 1 | $13 |
How this compares
$3,340 in reported general payments places this provider in the 80th percentile of 1,284 internal medicine providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 50 | $59,811 |
| EliquisApixaban | 74 | $55,834 |
| OzempicSemaglutide | 21 | $39,768 |
| JanuviaSitagliptin Phosphate | 12 | $19,337 |
| Aimovig AutoinjectorErenumab-Aooe | 12 | $8,586 |
| Breo ElliptaFluticasone/Vilanterol | 19 | $8,364 |
| Tresiba Flextouch U-100Insulin Degludec | 11 | $7,524 |
| Atorvastatin Calcium | 418 | $4,127 |
| SynthroidLevothyroxine Sodium | 47 | $2,601 |
| Dexlansoprazole DrDexlansoprazole | 14 | $2,598 |
| Levothyroxine Sodium | 234 | $2,501 |
| Duloxetine Hcl | 63 | $2,424 |
| Pantoprazole Sodium | 153 | $2,311 |
| Potassium Chloride | 46 | $1,914 |
| Esomeprazole Magnesium | 35 | $1,876 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $232 | $59,81150 claims |
| PfizerEliquis | $405 | $55,83474 claims |
| Novo NordiskOzempic | $274 | $39,76821 claims |
| MerckJanuvia | $70 | $19,33712 claims |
| GSKBreo Ellipta | $252 | $8,36419 claims |
| AbbVieSynthroid | $536 | $2,60147 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,284 internal medicine providers in Kentucky.
Other internal medicine in Lexington
- Neil FarrisLexington$3M
- David ManninoLexington$168K
- John BordersLexington$166K
- Fadi BachaLexington$31K
- James BordersLexington$31K
- Jad BalloutLexington$30K
- Thomas von UnrugLexington$22K
- Danilo CoralesLexington$17K
- Mohamed TashaniLexington$17K
- Kelli TrentLexington$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.